CWS Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-382
| Closed | -$74.9K | – | 150 |
|
|
2023
Q3 | $74.9K | Buy |
+382
| New | +$74.9K | 0.03% | 153 |
|
|
2023
Q1 | – | Sell |
-1,045
| Closed | -$303K | – | 149 |
|
|
2022
Q4 | $303K | Buy |
+1,045
| New | +$303K | 0.13% | 106 |
|
|
2021
Q2 | $358K | Sell |
967
-78
| -7% | -$28.9K | 0.14% | 105 |
|
|
2021
Q1 | $303K | Buy |
1,045
+9
| +0.9% | +$2.61K | 0.13% | 106 |
|
|
2020
Q4 | $259K | Buy |
1,036
+12
| +1% | +$3K | 0.15% | 107 |
|
|
2020
Q3 | $232K | Buy |
+1,024
| New | +$232K | 0.15% | 108 |
|